Daniel Crona, PharmD, PhD
University of North Carolina, Chapel Hill
3
3
3
N/A
0
3
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Vimal Derebail, MD, MPH
University of North Carolina, Chapel Hill
Shared therapeutic areas:
Worked with same sponsors:
Beata Holkova, MD
Massey Cancer Center
Shared therapeutic areas:
K A Bradstock), Dr.
Westmead Hospital
Shared therapeutic areas:
J Szer, Dr.
Royal Melbourne Hospital, Parkville, Australia
Shared therapeutic areas:
E Gluckman, Dr.
Hopital St Louis, Paris, France
Shared therapeutic areas:
J Rowe, Dr.
Rambam Medical Center, Haifa, Israel
Shared therapeutic areas:
G Lambertenghi-Deliliers, Dr.
Padiglione G Marcora, Ospedale Maggiore di Milano, Italy
Shared therapeutic areas:
T Ruutu, Dr.
Helsinki University CT. Rentral Hospital, Finland
Shared therapeutic areas:
Jorge Cortes, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Yifan Zhai, MD, PhD
Ascentage Pharma Group Inc.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome
Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients
Pharmacokinetics of Apixaban in Nephrotic Syndrome
All 3 trials loaded